The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVersarien Regulatory News (VRS)

Share Price Information for Versarien (VRS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.0982
Bid: 0.098
Ask: 0.1045
Change: -0.0023 (-2.29%)
Spread: 0.0065 (6.633%)
Open: 0.10
High: 0.10
Low: 0.0982
Prev. Close: 0.1005
VRS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of General Meeting

12 Oct 2023 07:00

RNS Number : 8443P
Versarien PLC
12 October 2023

12 October 2023

Versarien plc

("Versarien" or the "Company")

Notice of General Meeting

Versarien plc (AIM: VRS), the advanced materials engineering group, announces that a Notice of General Meeting ("General Meeting") will be posted to shareholders today. The General Meeting will be held on Monday 30 October 2023 at 10.00 a.m. at the offices of Fieldfisher LLP, Riverbank House, 2 Swan Lane, London EC4R 3TT. The purpose of the General Meeting is to approve a share capital reorganisation, which consists of a redesignation of the existing ordinary shares of the Company, and renewal of the Company's share capital authorities.

The formal notice of the General Meeting including full details of all resolutions to be proposed ("Resolutions") is available to view on the Company's website at www.versarien.com.

The Company values shareholder participation and values the votes of shareholders, so it encourages all shareholders to exercise their voting rights by completing and submitting a proxy form as soon as possible. It would also be helpful if shareholders could submit any questions in advance of the General Meeting via IFC Advisory Limited, the Company's financial PR and investor relations adviser, at versarien@investor-focus.co.uk.

Background

At the last general meeting of the Company, held on 4 July 2023, the Company explained that it wished to renew its share capital authorities to enable it to provide bridging finance whilst certain assets were marketed for sale.

As described in the commercial update on 2 October 2023, discussions remain ongoing regarding the sale of these assets, but at this juncture there can be no certainty that sales can be satisfactorily concluded before the existing working capital is exhausted and consequently further funding may be required from the capital markets.

However, the Company's existing ordinary shares have, at times, traded on AIM at a price less than the nominal value of such shares. Under the Companies Act 2006, a company is unable to issue shares at a subscription price which is less than the nominal value of shares of the same class. This means that, as the nominal value of the Company's existing ordinary shares is currently one penny, the Company could not issue further Ordinary Shares at a price of less than one penny per share without a reorganisation of the existing ordinary shares. The Board, therefore, considers it prudent to implement the proposed share capital reorganisation in order that the nominal value of the new ordinary shares becomes lower than one penny therefore allowing the Company the possibility to raise funds by issuing further shares, should the Directors elect to do so in due course.

Additionally, the lower share price means that the authorities granted at the Company's previous general meeting have scope to generate less aggregate funds so the directors are seeking shareholder approval to also renew those authorities to potentially generate greater working capital for the Company's short and medium term needs.

Share Capital Reorganisation and amendments to the Articles of Association

Accordingly, it is proposed to reorganise the existing ordinary share of 1p each ("Existing Ordinary Share") into one new ordinary share of 0.1p ("New Ordinary Share") and one new deferred share of 0.9p each ("New Deferred Share").

The New Ordinary Shares will in all material respects, have the same rights (including rights as to voting, dividends and return of capital) as the Existing Ordinary Shares. The New Ordinary Shares will be traded on AIM in the same way as the Existing Ordinary Shares, with the exception of the difference in nominal value.

The rights attached to the New Deferred Shares will be set out in the Articles (as per Resolution 2 in the Notice of General Meeting). The New Deferred Shares will have little economic value as they will not carry any rights to vote or dividend rights, although the New Deferred Shares will rank pari passu with the New Ordinary Shares on a return of capital on a winding up of the Company.

The Company does not intend to make any application for the New Deferred Shares to be admitted to trading on AIM or any other public market. The New Deferred Shares will not be transferable without the prior written consent of the Company. No share certificates will be issued in respect of the New Deferred Shares. The Board may further appoint any person to act on behalf of all the holders of the New Deferred Shares to transfer all such shares to the Company in accordance with the terms of the Companies Act.

It is not intended to issue new share certificate(s) to the holders of the New Ordinary Shares following the Share Capital Reorganisation. Existing share certificate(s) will remain valid for the same number of shares but with a different nominal value of 0.1p per share. Following the Share Capital Reorganisation should you wish to receive an updated share certificate please contact the Registrars at the address set out in this document. The nominal value of shares already held in CREST will be updated at approximately 8.00 a.m. on 31 October 2023.

By effecting the Share Capital Reorganisation in this way, the total nominal value of the Company's entire issued share capital remains the same with New Ordinary Shares having a nominal value of 0.1p plus New Deferred Shares having a nominal value of 0.9p.

The Share Capital Reorganisation is conditional upon, and effected by, the approval of Resolutions 1 and 2 at the General Meeting as required by the Companies Act 2006 and the Articles. If Resolutions 1 and 2 are passed, the Share Capital Reorganisation will become effective at 6.00 p.m. on the Record Date.

The Articles are proposed to be amended to allow for the issue of the New Deferred Shares, which are proposed to be issued as part of the Share Capital Reorganisation. Resolution 2 amends the Company's existing Articles to include provision in respect of the rights and restrictions attaching to the Deferred Shares. The changes are set out in Part 2 of the Circular.

Recommendation

The Board considers that the Resolutions are in the best interests of the Company and its shareholders, taken as a whole. The Board unanimously recommends that the Shareholders to vote in favour of the Resolutions, as the Directors intend to do so in respect of their own beneficial holdings.

If the Resolutions are not approved at the General Meeting, the Company may not be able to raise equity funding, and if no alternative funding can be secured, the Company's ability to operate as a going concern will be put at risk.

Expected timetable of principal events 2023

Publication and dispatch of the circular and Form of Proxy 12 October

Latest time and date for receipt of the Form of Proxy 10.00 a.m. on 26 October

Time and date of the General Meeting 10.00 a.m. on 30 October

Results of the General Meeting announced through RNS 30 October

Record Date for Share Capital Reorganisation 6.00 p.m. on 30 October

Admission and dealings in New Ordinary Shares 8.00 a.m. on 31 October

All references to times in this timetable are to London times and each of the times and dates are indicative only and may be subject to change.

Terms used and not defined in this announcement shall have the same meanings given to them in the Notice of General Meeting.

For further information please contact:

Versarien

Stephen Hodge, Chief Executive Officer

Chris Leigh, Chief Financial Officer

c/o IFC

SP Angel Corporate Finance (Nominated Adviser and Broker)

Matthew Johnson, Adam Cowl

+44 (0)20 3470 0470

IFC Advisory Limited (Financial PR and Investor Relations)

Tim Metcalfe, Zach Cohen

+44 (0) 20 3934 6630

For further information please see: http://www.versarien.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
NOGGPGUAUUPWGQG
Date   Source Headline
12th Feb 20204:35 pmRNSPrice Monitoring Extension
11th Feb 20204:40 pmRNSSecond Price Monitoring Extn
11th Feb 20204:36 pmRNSPrice Monitoring Extension
11th Feb 20202:05 pmRNSSecond Price Monitoring Extn
11th Feb 20202:00 pmRNSPrice Monitoring Extension
11th Feb 202011:05 amRNSSecond Price Monitoring Extn
11th Feb 202011:00 amRNSPrice Monitoring Extension
10th Feb 20207:00 amRNSResponse to share price movement
21st Jan 20207:00 amRNSUS Update
18th Dec 20197:00 amRNSAirbus Graphene Flagship Project
12th Dec 20197:00 amRNSInterim Results
27th Nov 20197:00 amRNSNotice of Results
27th Nov 20197:00 amRNSTextile Commercial Partnership Agreement
1st Nov 20192:05 pmRNSSecond Price Monitoring Extn
1st Nov 20192:00 pmRNSPrice Monitoring Extension
9th Oct 20197:00 amRNSRefractory Materials Collaboration
24th Sep 20191:38 pmRNSResult of AGM
24th Sep 20197:00 amRNSAGM Statement
20th Sep 201911:47 amRNSSecond Price Monitoring Extn
20th Sep 201911:46 amRNSPrice Monitoring Extension
19th Sep 20192:05 pmRNSSecond Price Monitoring Extn
19th Sep 20192:00 pmRNSPrice Monitoring Extension
22nd Aug 20199:35 amRNSAppointment of Joint Broker
21st Aug 20191:35 pmRNSNotice of AGM and Posting of Annual Report
9th Aug 20197:54 amRNSChina Update and Clarification
6th Aug 20197:00 amRNSAnnual General Meeting
26th Jul 20197:00 amRNSLOI with Global Apparel Manufacturer
24th Jul 20197:00 amRNSTransport Infrastructure Technology Preview Event
17th Jul 20197:00 amRNSPreliminary Results
16th Jul 20197:00 amRNSInvestor Event
15th Jul 20198:00 amRNSReceipt of Graphene REACH Registration
11th Jul 201910:30 amRNSNotice of Results
8th Jul 20197:00 amRNSJapanese Graphene Order
1st Jul 20197:00 amRNSAppointment of Director
28th Jun 20197:00 amRNSUS Graphene Order
27th Jun 20192:33 pmRNSAppointment of New Head of US Operations
19th Jun 20192:16 pmRNSResponse to Commentary Regarding US Employee
29th May 20193:00 pmRNSCollaboration Agreement with BP Polymers
9th May 20197:00 amRNSUSA Update
15th Apr 20196:03 pmRNSDirector/PDMR Shareholding
15th Apr 20197:00 amRNSTerm Sheet with Beijing Institute of Graphene Tech
4th Apr 20198:29 amRNSUS Appointment Update
1st Apr 20197:00 amRNSCompletion of Verified Graphene Producer Programme
29th Mar 20197:00 amRNSExtension of DIT Secondment
21st Mar 20197:00 amRNSUSA Update
14th Mar 20197:00 amRNSLOI with Tunghsu Optoelectronic
7th Mar 201911:42 amRNSFurther Chinese Aerospace Collaboration
5th Mar 20199:00 amRNSPrice Monitoring Extension
1st Mar 20192:05 pmRNSSecond Price Monitoring Extn
1st Mar 20192:00 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.